7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Study design affects participant expectations: a survey.

      Journal of Clinical Psychopharmacology
      Adolescent, Adult, Antidepressive Agents, therapeutic use, Controlled Clinical Trials as Topic, methods, Depressive Disorder, drug therapy, Female, Humans, Male, Placebo Effect, Questionnaires, Research Design, Research Subjects, psychology, Treatment Outcome, Young Adult

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Evidence suggests that clinical trial participants have higher expectations of improvement when they know they are receiving active treatment versus when they are aware they may receive placebo, but this has not been directly tested. The goal of this survey was to determine whether respondents report higher expectations of improvement in comparator versus placebo-controlled clinical trials. A questionnaire describing 2 hypothetical clinical trials was distributed to undergraduates in an introductory psychology course. The questionnaire describes 1 trial in which medication is compared with placebo and another in which the same medication is compared with another medication. Respondents rated their expectations of improvement should they participate in each trial without knowing their specific treatment assignment. Questions measured the magnitude and the likelihood of expected improvement on a 9-point Likert scale. Thirty-seven undergraduates, 69% female and mean age of 22.4 +/- 6.8 years, participated in the study. Respondents reported a significantly higher expected likelihood of improvement in a comparator trial compared with a placebo-controlled trial (7.2 +/- 2.1 vs 5.3 +/- 1.6, t(36) = -4.96, P < 0.001). Similarly, they reported a significantly higher expected magnitude of improvement in a comparator trial compared with a placebo-controlled trial (7.2 +/- 1.9 vs 4.9 +/- 1.4, t(35) = -6.74, P < 0.001). These results support the hypothesis that clinical trial design influences participant expectations of improvement. Study design may affect clinical outcomes and should be kept in mind when interpreting the results of antidepressant clinical trials.

          Related collections

          Author and article information

          Comments

          Comment on this article